MAGE-1 and -3 Genes in Liver Cancer
Author Information
Author(s): Kariyama K, Higashi T, Kobayashi Y, Nouso K, Nakatsukasa H, Yamano T, Ishizaki M, Kaneyoshi T, Toshikuni N, Ohnishi T, Fujiwara K, Nakayama E, Terracciano L, Spagnoli G C, Tsuji T
Primary Institution: Okayama University Medical School
Hypothesis
The study investigates the expression of MAGE-1 and -3 genes and their proteins in human hepatocellular carcinoma.
Conclusion
The study found that MAGE-1 and -3 proteins are expressed in a significant percentage of hepatocellular carcinomas, suggesting their potential as targets for immunotherapy.
Supporting Evidence
- MAGE-1 mRNAs were expressed in 78% of hepatocellular carcinomas.
- MAGE-3 mRNAs were expressed in 42% of hepatocellular carcinomas.
- MAGE-1 proteins were detected in 18% of the tumors analyzed.
- MAGE-3 proteins were detected in 7% of the tumors analyzed.
- Western blotting showed MAGE-1 and -3 proteins expressed in 80% and 60% of examined tumors, respectively.
- The expression of MAGE-1 and -3 was consistent regardless of histological grading and clinical staging.
Takeaway
This study looked at how certain genes related to cancer are found in liver tumors, which could help doctors find and treat these tumors better.
Methodology
The study used reverse-transcription polymerase chain reaction (RT-PCR), immunohistochemical analysis, and Western blotting to analyze gene and protein expression.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website